Bioqual, Inc. (BIOQ)
USD 55.0
(-4.35%)
USD 55.0
(-4.35%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 7.44 Million USD | -35.23% |
| 2022 | 11.49 Million USD | 77.67% |
| 2021 | 6.47 Million USD | 19.47% |
| 2020 | 5.41 Million USD | 24.09% |
| 2019 | 4.36 Million USD | 14.1% |
| 2018 | 3.82 Million USD | 10.82% |
| 2017 | 3.45 Million USD | 2.76% |
| 2016 | 3.35 Million USD | 18.25% |
| 2015 | 2.84 Million USD | -4.51% |
| 2014 | 2.97 Million USD | -15.71% |
| 2013 | 3.53 Million USD | 2.63% |
| 2012 | 3.43 Million USD | 0.0% |
| 2010 | 3.88 Million USD | 2.17% |
| 2009 | 3.79 Million USD | 0.0% |
| 2006 | 3.04 Million USD | 4.69% |
| 2005 | 2.91 Million USD | 8.4% |
| 2004 | 2.68 Million USD | 5.85% |
| 2003 | 2.53 Million USD | 3.43% |
| 2002 | 2.45 Million USD | 0.0% |
| 2000 | 2.31 Million USD | 1.73% |
| 1999 | 2.27 Million USD | 5.93% |
| 1998 | 2.14 Million USD | 5.72% |
| 1997 | 2.03 Million USD | 3.62% |
| 1996 | 1.95 Million USD | 19.26% |
| 1995 | 1.64 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 1.56 Million USD | 3.7% |
| 2023 Q4 | 1.51 Million USD | -28.14% |
| 2023 Q3 | 2.1 Million USD | 6.66% |
| 2023 Q1 | 1.85 Million USD | -8.93% |
| 2023 Q2 | 1.97 Million USD | 6.32% |
| 2022 Q3 | 1.93 Million USD | 6.74% |
| 2022 Q2 | 1.81 Million USD | 3.76% |
| 2022 Q1 | 1.74 Million USD | 189.91% |
| 2022 FY | 7.54 Million USD | 16.52% |
| 2022 Q4 | 2.03 Million USD | 5.2% |
| 2021 Q4 | 603.54 Thousand USD | -70.25% |
| 2021 FY | 6.47 Million USD | 19.47% |
| 2021 Q3 | 2.02 Million USD | -4.5% |
| 2021 Q1 | 1.71 Million USD | 62.08% |
| 2021 Q2 | 2.12 Million USD | 23.83% |
| 2020 Q1 | 1.45 Million USD | -65.16% |
| 2020 Q3 | 1.48 Million USD | 3.65% |
| 2020 Q4 | 1.05 Million USD | -28.49% |
| 2020 FY | 5.41 Million USD | 24.09% |
| 2020 Q2 | 1.42 Million USD | -1.57% |
| 2019 FY | 4.36 Million USD | 14.1% |
| 2019 Q3 | 1.31 Million USD | -7.54% |
| 2019 Q1 | 1.16 Million USD | -67.32% |
| 2019 Q4 | 4.16 Million USD | 217.57% |
| 2019 Q2 | 1.41 Million USD | 21.54% |
| 2018 Q3 | 1.21 Million USD | -0.44% |
| 2018 Q1 | 1.13 Million USD | 385.56% |
| 2018 FY | 3.82 Million USD | 10.82% |
| 2018 Q4 | 3.56 Million USD | 194.17% |
| 2018 Q2 | 1.21 Million USD | 7.09% |
| 2017 Q3 | 1.05 Million USD | -2.34% |
| 2017 FY | 3.45 Million USD | 2.76% |
| 2017 Q1 | 1.13 Million USD | -66.18% |
| 2017 Q2 | 1.07 Million USD | -5.21% |
| 2017 Q4 | 234.4 Thousand USD | -77.69% |
| 2016 Q1 | 1.08 Million USD | 1195.41% |
| 2016 FY | 3.35 Million USD | 18.25% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q4 | 3.35 Million USD | 0.0% |
| 2016 Q2 | - USD | -100.0% |
| 2015 FY | 2.84 Million USD | -4.51% |
| 2015 Q4 | 83.55 Thousand USD | -91.94% |
| 2015 Q3 | 1.03 Million USD | 14.48% |
| 2015 Q2 | 906.04 Thousand USD | -4.14% |
| 2015 Q1 | 945.21 Thousand USD | 226.37% |
| 2014 Q4 | 289.61 Thousand USD | -68.68% |
| 2014 FY | 2.97 Million USD | -15.71% |
| 2014 Q1 | 843.55 Thousand USD | -18.1% |
| 2014 Q2 | 917.35 Thousand USD | 8.75% |
| 2014 Q3 | 924.82 Thousand USD | 0.81% |
| 2013 FY | 3.53 Million USD | 2.63% |
| 2013 Q4 | 1.02 Million USD | 11.17% |
| 2013 Q2 | 781.39 Thousand USD | -1.36% |
| 2013 Q3 | 926.52 Thousand USD | 18.57% |
| 2013 Q1 | 792.15 Thousand USD | 3.39% |
| 2012 Q3 | 828.46 Thousand USD | -29.28% |
| 2012 Q4 | 766.16 Thousand USD | -7.52% |
| 2012 Q2 | 1.17 Million USD | 0.0% |
| 2012 FY | 3.43 Million USD | 0.0% |
| 2011 Q1 | 1.01 Million USD | 0.38% |
| 2010 FY | 3.88 Million USD | 2.17% |
| 2010 Q4 | 1 Million USD | 5.41% |
| 2010 Q3 | 955.15 Thousand USD | 2.03% |
| 2010 Q1 | 984.23 Thousand USD | -4.02% |
| 2010 Q2 | 936.16 Thousand USD | -4.88% |
| 2009 FY | 3.79 Million USD | 0.0% |
| 2009 Q4 | 1.02 Million USD | 32.14% |
| 2009 Q3 | 776.03 Thousand USD | -16.88% |
| 2009 Q2 | 933.64 Thousand USD | 0.0% |
| 2006 Q3 | 742.29 Thousand USD | 3.2% |
| 2006 Q4 | 875.01 Thousand USD | 17.88% |
| 2006 Q2 | 719.3 Thousand USD | 0.96% |
| 2006 Q1 | 712.44 Thousand USD | -6.74% |
| 2006 FY | 3.04 Million USD | 4.69% |
| 2005 Q3 | 715.94 Thousand USD | -1.72% |
| 2005 Q2 | 728.45 Thousand USD | 3.45% |
| 2005 FY | 2.91 Million USD | 8.4% |
| 2005 Q1 | 704.14 Thousand USD | 0.0% |
| 2005 Q4 | 763.95 Thousand USD | 6.71% |
| 2004 FY | 2.68 Million USD | 5.85% |
| 2003 FY | 2.53 Million USD | 3.43% |
| 2002 FY | 2.45 Million USD | 0.0% |
| 2001 Q1 | 569.05 Thousand USD | 0.73% |
| 2001 Q2 | 558.3 Thousand USD | -1.89% |
| 2001 Q3 | 589.61 Thousand USD | 5.61% |
| 2000 Q4 | 564.95 Thousand USD | -17.79% |
| 2000 FY | 2.31 Million USD | 1.73% |
| 2000 Q3 | 687.16 Thousand USD | 27.82% |
| 2000 Q2 | 537.6 Thousand USD | 2.78% |
| 2000 Q1 | 523.04 Thousand USD | -15.85% |
| 1999 FY | 2.27 Million USD | 5.93% |
| 1999 Q4 | 621.56 Thousand USD | 7.45% |
| 1999 Q2 | 533.39 Thousand USD | 0.0% |
| 1999 Q3 | 578.49 Thousand USD | 8.46% |
| 1998 FY | 2.14 Million USD | 5.72% |
| 1997 FY | 2.03 Million USD | 3.62% |
| 1996 FY | 1.95 Million USD | 19.26% |
| 1995 FY | 1.64 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Bio Medica Corporation | 1.04 Million USD | -610.083% |
| Arrayit Corporation | 6.19 Million USD | -20.188% |
| Atlantic International Corp. | 5.57 Million USD | -33.532% |
| Biocept, Inc. | 29.4 Million USD | 74.665% |
| CardioGenics Holdings Inc | 772.14 Thousand USD | -864.689% |
| DermTech, Inc. | 104.01 Million USD | 92.839% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 166.5 Million USD | 95.526% |
| HTG Molecular Diagnostics, Inc. | 22.62 Million USD | 67.075% |
| iMD Companies, Inc. | 151.8 Thousand USD | -4806.673% |
| IDenta Corp. | 662.97 Thousand USD | -1023.537% |
| Interpace Biosciences, Inc. | 20.23 Million USD | 63.183% |
| Integrative Health Technologies, Inc. | 38.88 Thousand USD | -19057.869% |
| InVitro International | 661.32 Thousand USD | -1026.342% |
| Lumos Diagnostics Holdings Limited | 7.09 Million USD | -4.942% |
| Many Bright Ideas Technologies Inc. | 58.11 Thousand USD | -12717.957% |
| Medical Imaging Corp. | 1.91 Million USD | -289.547% |
| NovelStem International Corp. | 3.53 Million USD | -110.548% |
| Optigenex Inc. | 1.28 Million USD | -478.38% |
| PharmChem, Inc. | 2.93 Million USD | -154.118% |
| Proteome Sciences plc | 3.26 Million USD | -127.931% |
| Response Genetics, Inc | 25.31 Million USD | 70.58% |
| Rennova Health, Inc. | 7.67 Million USD | 2.983% |
| RushNet, Inc. | 1.78 Million USD | -316.291% |
| ScreenPro Security Inc. | 3.23 Million USD | -129.977% |
| Stella Diagnostics Inc. | 11.42 Million USD | 34.814% |
| StageZero Life Sciences Ltd. | 7.34 Million USD | -1.44% |
| Todos Medical Ltd. | 14.05 Million USD | 47.014% |